|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007113,
umls-concept:C0030705,
umls-concept:C0032743,
umls-concept:C0046056,
umls-concept:C0205179,
umls-concept:C0220901,
umls-concept:C0332293,
umls-concept:C0439807,
umls-concept:C0543467,
umls-concept:C0600558,
umls-concept:C1514983,
umls-concept:C1517927,
umls-concept:C1559154,
umls-concept:C1999230,
umls-concept:C2607943,
umls-concept:C2926606
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-1-4
|
|
pubmed:abstractText |
Predicting outcome after aggressive therapy for advanced rectal cancer remains difficult. (18)F-FDG PET has emerged as a valid method for predicting patient outcomes after therapy in an increasing number of cancers. We evaluated the prognostic information obtained from the degree of change in tumor (18)F-FDG PET uptake induced by chemoradiation before radical curative surgery in patients with T3/T4 rectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
14-22
|
|
pubmed:meshHeading |
pubmed-meshheading:16391182-Adult,
pubmed-meshheading:16391182-Aged,
pubmed-meshheading:16391182-Aged, 80 and over,
pubmed-meshheading:16391182-Antineoplastic Agents,
pubmed-meshheading:16391182-Chemotherapy, Adjuvant,
pubmed-meshheading:16391182-Female,
pubmed-meshheading:16391182-Fluorodeoxyglucose F18,
pubmed-meshheading:16391182-Humans,
pubmed-meshheading:16391182-Male,
pubmed-meshheading:16391182-Middle Aged,
pubmed-meshheading:16391182-Neoadjuvant Therapy,
pubmed-meshheading:16391182-Neoplasm Recurrence, Local,
pubmed-meshheading:16391182-Positron-Emission Tomography,
pubmed-meshheading:16391182-Prognosis,
pubmed-meshheading:16391182-Radiopharmaceuticals,
pubmed-meshheading:16391182-Radiotherapy, Adjuvant,
pubmed-meshheading:16391182-Rectal Neoplasms,
pubmed-meshheading:16391182-Reproducibility of Results,
pubmed-meshheading:16391182-Risk Assessment,
pubmed-meshheading:16391182-Risk Factors,
pubmed-meshheading:16391182-Sensitivity and Specificity,
pubmed-meshheading:16391182-Survival Analysis,
pubmed-meshheading:16391182-Survival Rate,
pubmed-meshheading:16391182-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
|
|
pubmed:affiliation |
Center For Molecular Imaging, The Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
